14159, L.P., 10% Owner at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 1,136,364 shares at $4.40 ($5.0M) on 2013-08-01, disclosed to the SEC on 2013-08-02.
Open-market purchase of $5.0M BCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.40 | 24,705 | $109K | 2.2% |
| 2 | $4.40 | 120,498 | $530K | 10.6% |
| 3 | $4.40 | 991,161 | $4.4M | 87.2% |
| Total | $4.40 avg | 1,136,364 | $5.0M | 100% |
| Filing → |
| GHDX | SELL | 2019-01-14 | $2.8M | — | Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-12-03 | $15.9M | — | Filing → |